Cognitive Function Development Therapy
Cognitive Function Development Therapy (CFDT) is a neuroscience based treatment modality that targets brain imbalances by promoting reallocation of neural resources for desired far-reaching transference effects. Using objective assessments of primary cognitive functions to direct treatment, CFDT targets lower functions to promote cognitive resource development, and produce a more adaptive nervous system functioning. CFD therapy utilizes dynamically interactive activities with either a competitive or collaborative presentation to stimulate and drive the targeted neuroplastic remodeling. Outcomes include reduced or eliminated dependence on medications, successful completion of traditional therapies, and achievements beyond clinical success such as improved relationships and better academic/vocational performance.
For more information, check out the Cognitive Function Development Institute
Pharmacogenomics (PGx) Test
Precision Medicine
Many factors influence a patient’s treatment and response to medications. Pharmacogenomics (PGx) is an objective component to provide personalized treatment and improve clinical outcomes.
The Tempus nP pharmacogenomic test informs medication selection and dosing for patients experiencing depression, anxiety, ADHD and other mental health conditions.
A buccal swab is used for simplified sample collection. Sample collection kits may be mailed directly to patient homes. CLICK Tempus for more information regarding insurance coverage, copays, and resources.
Digital Therapeutics
Digital therapeutics are evidence-based therapeutic interventions that are delivered through software programs to prevent, manage, or treat medical conditions. These are often regulated by health authorities like the FDA in the U.S.